Blood Test Outperforms Ultrasound in Early Liver Cancer Detection, Study Finds
A multicenter clinical trial found the HelioLiver blood test detected early-stage liver cancer with 71.9% sensitivity, outperforming ultrasound’s 36.8%.
Read MorePosted by CLP Edit Staff | May 19, 2026 | Cancer, Diagnostic Technologies, Molecular Diagnostics |
A multicenter clinical trial found the HelioLiver blood test detected early-stage liver cancer with 71.9% sensitivity, outperforming ultrasound’s 36.8%.
Read MorePosted by CLP Edit Staff | Apr 24, 2026 | Cancer, Cytology, Womens Health |
Utepreva LLC has received FDA clearance for its single-use endometrial sampler, which employs three sampling mechanisms to improve tissue yield for cytologic and molecular analysis in early endometrial cancer detection.
Read MorePosted by CLP Edit Staff | Apr 22, 2026 | Compliance, Diagnostic Technologies, Lab Management |
A new analysis finds that policy and payment gaps are limiting access to diagnostics, with nearly half the world lacking adequate testing and reimbursement lagging behind advances in precision therapies.
Read MorePosted by CLP Edit Staff | Mar 26, 2026 | Lab Management |
A national eMERGE study found that genetic risk results can be returned at scale, with over 70% of high-risk patients receiving counseling, though disparities in access persist, according to the American Journal of Human Genetics.
Read MorePosted by CLP Edit Staff | Mar 17, 2026 | Diabetes & Metabolic Diseases |
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
Read More